MedPath

Observational study of the benefits of rectal ozonotherapy and BIOPLA as complemetary theraphy in convalescent patients with SARS-COV 2

Not Applicable
Completed
Conditions
COVID-19
SARS-CoV2
Coronavirus Infections
SARS Virus
Coronaviridae Infections
Nidovirales Infections
Betacoronavirus
Registration Number
RPCEC00000342
Lead Sponsor
ational Center for Scientific Research
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
40
Inclusion Criteria

Hospitalization patients convalescient with SARS-CoV 2, bewteen 40 and 80 years , both sexes, signed informed consent.

Exclusion Criteria

1) Patients with uncontrolled hypertiroidism
2) Patients with deficit of glucose-6-phosphateo-deshidrogenase
3) Non transmissible cronic diseases
4) Oncological patients
5) Patients with psiquiatric diseases
6) Surgery
7) Patients use inmunosupresant or patients with trasplant
8) Patiens with coagulation , trombocitopenia or active bleed
9) Allergic patients
10) Patients participate in other clinical trials 3 months before

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.